Anvisa (National Health Surveillance Agency) approved the indication of injectable dexamethasone for the treatment of Covid-19. The new therapeutic indication will be published in the Official Gazette this Friday (16).
The drug should be used in patients with severe or critical Covid-19. The request for a new indication for the drug was made by Aché Laboratories.
Tests show that this drug reduces the risk of death by one-fifth for patients on oxygen support and by one-third for patients requiring mechanical ventilation.
It is also such a cheap drug that it has been used in various parts of the world to treat Covid-19, from Brazil to China.
The inclusion of a new indication for the drug was based on the recommendations of the WHO (World Health Organization) published in the document Therapeutics and Covid-19: living guideline, and on manifestations by equivalent foreign regulatory authorities, such as the EMA (European Medicines Agency).
“Anvisa warns that no medicine for Covid-19 replaces the approved vaccines”, said the agency, through a note.
your subscription can be worth even more
Do you already know the advantages of being a Folha subscriber? In addition to having access to reports and columns, you have exclusive newsletters (find out here). You can also download our free app from the Apple Store or Google Play to receive alerts for the top news of the day. Your subscription helps us to create independent and quality journalism. Thanks!
your signature is worth a lot
More than 180 reports and analyzes published each day. A team with more than 200 columnists and bloggers. Professional journalism that supervises public authorities, conveys useful and inspiring news, counterpoints the intolerance of social networks and draws a clear line between truth and lies. How much does it cost to help produce this content?
SUBSCRIBE FOR BRL 1.90 IN THE 1st MONTH
I have over 8 years of experience in the news industry. I have worked for various news websites and have also written for a few news agencies. I mostly cover healthcare news, but I am also interested in other topics such as politics, business, and entertainment. In my free time, I enjoy writing fiction and spending time with my family and friends.
